<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39315691</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-0012</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical transplantation</Title><ISOAbbreviation>Clin Transplant</ISOAbbreviation></Journal><ArticleTitle>A Multi-Center International Analysis of Lung Transplantation Outcomes in Patients With COVID-19.</ArticleTitle><Pagination><StartPage>e15462</StartPage><MedlinePgn>e15462</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ctr.15462</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Lung transplantation has become increasingly utilized in patients with COVID-19. While several single-center and UNOS database studies have been published on lung transplants (LTs) for end-stage lung disease (ESLD) from Coronavirus disease 2019 (COVID-19), there is a lack of multi-center and international data.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a multicenter analysis from 11 high-volume lung transplant centers in the United States and Europe. Data were collected through the Multi-Institutional ECLS Registry and stratified by ESLD due to COVID-19 versus other etiologies. Demographics and clinical variables were compared using Chi-square test and Fisher's exact test. Survival was assessed by Kaplan-Meier curves and compared by log-rank test with propensity score matching.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1606 lung transplant recipients, 46 (2.9%) were transplanted for ESLD from COVID-19 compared to 1560 (97.1%) without a history of COVID-19. Among COVID-19 patients, 30 (65.2%) had COVID-19-associated ARDS and 16 (34.8%) had post-COVID-19 fibrosis. COVID-19 patients had higher lung allocation scores (78.0 vs. 44.4, p &lt; 0.0001), had severely limited functional status (37.0% vs. 2.9%, p &lt; 0.0001), had higher preoperative ECMO usage (65.2% vs. 5.4%, p &lt; 0.0001), and spent less time on the waitlist (32 vs. 137 days, p &lt; 0.0001). A 30-day survival was comparable between COVID-19 and non-COVID-19 patients before (100% vs. 98.7%, p = 0.39) and after propensity matching (p = 0.15).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients who received LTs due to COVID-19 had short-term survival comparable to that of patients without COVID-19. Our findings support the idea that lung transplantation should be considered for select patients with ESLD due to COVID-19.</AbstractText><CopyrightInformation>© 2024 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kashem</LastName><ForeName>Mohammed Abul</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loor</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7275-2434</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplant and Circulatory Support, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emtiazjoo</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartwig</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Raemdonck</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1261-0992</Identifier><AffiliationInfo><Affiliation>Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvelli</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6984-6352</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leon Pena</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplant and Circulatory Support, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salan-Gomez</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3436-6871</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplant and Circulatory Support, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Huaqing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warnick</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villavicencio</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ius</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghadimi</LastName><ForeName>Kamrouz</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Medical Center, Raleigh, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salman</LastName><ForeName>Jawad</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7172-2946</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandrashekaran</LastName><ForeName>Satish</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, Emory University Hospital, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machuca</LastName><ForeName>Tiago</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Lung Transplantation, University of Miami School of Medicine, Miami, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Pablo G</ForeName><Initials>PG</Initials><Identifier Source="ORCID">0000-0003-3607-0345</Identifier><AffiliationInfo><Affiliation>Department of Thoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramaniam</LastName><ForeName>Kathirvel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neyrinck</LastName><ForeName>Arne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huddleston</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9244-9854</Identifier><AffiliationInfo><Affiliation>Division of Cardiothoracic Surgery, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceulemans</LastName><ForeName>Laurens</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osho</LastName><ForeName>Asishana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1140-097X</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Silva</LastName><ForeName>Ethan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplant and Circulatory Support, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramamurthy</LastName><ForeName>Uma</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplant and Circulatory Support, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaffer</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Surgery, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langer</LastName><ForeName>Nathaniel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toyoda</LastName><ForeName>Yoshiya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Clin Transplant</MedlineTA><NlmUniqueID>8710240</NlmUniqueID><ISSNLinking>0902-0063</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016040" MajorTopicYN="Y">Lung Transplantation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fibrosis</Keyword><Keyword MajorTopicYN="N">lung (allograft) function/dysfunction</Keyword><Keyword MajorTopicYN="N">lung (native) function/dysfunction</Keyword><Keyword MajorTopicYN="N">patient survival</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>8</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39315691</ArticleId><ArticleId IdType="doi">10.1111/ctr.15462</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>WHO Coronavirus (COVID‐19) Dashboard, accessed September 9, 2023, https://covid19.who.int.</Citation></Reference><Reference><Citation>RECOVERY Collaborative Group, P. Horby, W. S. Lim, et al., “Dexamethasone in Hospitalized Patients With Covid‐19,” New England Journal of Medicine 384, no. 8 (2021): 693–704, https://doi.org/10.1056/NEJMoa2021436.</Citation></Reference><Reference><Citation>C. S. King, H. Mannem, J. Kukreja, et al., “Lung Transplantation for Patients With COVID‐19,” Chest 161, no. 1 (2022): 169–178, https://doi.org/10.1016/j.chest.2021.08.041.</Citation></Reference><Reference><Citation>OPTN Board Approves Transplant Candidate Diagnoses Associated With COVID‐19 Related Organ Failure—OPTN, accessed September 17, 2023, https://optn.transplant.hrsa.gov/news/optn‐board‐approves‐transplant‐candidate‐diagnoses‐associated‐with‐covid‐19‐related‐organ‐failure/.</Citation></Reference><Reference><Citation>S. C. van der Mark, R. A. S. Hoek, and M. E. Hellemons, “Developments in Lung Transplantation Over the Past Decade,” European Respiratory Review 29, no. 157 (2020): 190132, https://doi.org/10.1183/16000617.0132‐2019.</Citation></Reference><Reference><Citation>M. M. Weder, S. Aslam, and M. G. Ison, “Lung Transplantation for COVID‐19–Related Lung Disease: Clinical Experience and Call for a Global Registry,” Transplantation 107, no. 1 (2023): 18–20, https://doi.org/10.1097/TP.0000000000004327.</Citation></Reference><Reference><Citation>G. Loor, S. Huddleston, M. Hartwig, et al., “Effect of Mode of Intraoperative Support on Primary Graft Dysfunction After Lung Transplant,” Journal of Thoracic and Cardiovascular Surgery 164, no. 5 (2022): 1351–1361, https://doi.org/10.1016/j.jtcvs.2021.10.076.</Citation></Reference><Reference><Citation>K. Subramaniam, G. Loor, E. G. Chan, et al., “Intraoperative Red Blood Cell Transfusion and Primary Graft Dysfunction After Lung Transplantation,” Transplantation 107, no. 7 (2023): 1573–1579, https://doi.org/10.1097/TP.0000000000004545.</Citation></Reference><Reference><Citation>J. W. Suh, J. G. Lee, M. S. Park, S. Y. Kim, S. J. Jeong, and H. C. Paik, “Impact of Extended‐Criteria Donor Lungs According to Preoperative Recipient Status and Age in Lung Transplantation,” Korean Journal of Transplantation 34, no. 3 (2020): 185–192, https://doi.org/10.4285/kjt.2020.34.3.185.</Citation></Reference><Reference><Citation>G. I. Snell, R. D. Yusen, D. Weill, et al., “Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, Part I: Definition and Grading–A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation,” The Official Publication of the International Society for Heart and Lung Transplantation 36, no. 10 (2017): 1097–1103, https://doi.org/10.1016/j.healun.2017.07.021.</Citation></Reference><Reference><Citation>P. Tasoudis, L. J. Lobo, R. D. Coakley, et al., “Outcomes Following Lung Transplant for COVID‐19–Related Complications in the US,” JAMA Surgery 158 (2023): 1159–1166, https://doi.org/10.1001/jamasurg.2023.3489.</Citation></Reference><Reference><Citation>K. Okumura, S. Jyothula, T. Kaleekal, and A. Dhand, “1‐Year Outcomes of Lung Transplantation for Coronavirus Disease 2019–Associated End‐Stage Lung Disease in the United States,” Clinical Infectious Diseases 76, no. 12 (2023): 2140–2147, https://doi.org/10.1093/cid/ciad072.</Citation></Reference><Reference><Citation>C. Bermudez, F. Bermudez, A. Courtwright, et al., “Lung Transplantation for COVID‐2019 Respiratory Failure in the United States: Outcomes 1‐Year Posttransplant and the Impact of Preoperative Extracorporeal Membrane Oxygenation Support,” Journal of Thoracic and Cardiovascular Surgery 167, no. 1 (2024): 384–395, https://doi.org/10.1016/j.jtcvs.2023.04.016. e3.</Citation></Reference><Reference><Citation>K. Freischlag, T. J. Lynch, V. Ievlev, et al., “A Matched Survival Analysis of Lung Transplant Recipients With Coronavirus Disease 2019–Related Respiratory Failure,” Annals of Thoracic Surgery 116, no. 4 (2023): 819–828, https://doi.org/10.1016/j.athoracsur.2022.09.039.</Citation></Reference><Reference><Citation>C. Kurihara, A. Manerikar, M. Querrey, et al., “Clinical Characteristics and Outcomes of Patients With COVID‐19–Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant,” The Journal of the American Medical Association 327, no. 7 (2022): 1–10, https://doi.org/10.1001/jama.2022.0204.</Citation></Reference><Reference><Citation>E. Cerier, K. Lung, C. Kurihara, and A. Bharat, “Lung Transplantation in Coronavirus‐19 Patients,” Clinics in Chest Medicine 44, no. 2 (2023): 347–357, https://doi.org/10.1016/j.ccm.2022.11.017.</Citation></Reference><Reference><Citation>C. M. Roberts, M. Levi, M. McKee, R. Schilling, W. S. Lim, and M. P. W. Grocott, “COVID‐19: A Complex Multisystem Disorder,” British Journal of Anaesthesia 125, no. 3 (2020): 238–242, https://doi.org/10.1016/j.bja.2020.06.013.</Citation></Reference><Reference><Citation>G. Sunagawa, H. Kehara, C. Mangukia, et al., “Single Lung Transplant Remains a Viable Option for Patients With Severe Secondary Pulmonary Hypertension,” Transplantation 106, no. 11 (2022): 2241–2246, https://doi.org/10.1097/TP.0000000000004191.</Citation></Reference><Reference><Citation>A. Bharat, T. N. Machuca, M. Querrey, et al., “Early Outcomes After Lung Transplantation for Severe COVID‐19: A Series of the First Consecutive Cases From Four Countries,” Lancet Respiratory Medicine 9, no. 5 (2021): 487–497, https://doi.org/10.1016/S2213‐2600(21)00077‐1.</Citation></Reference><Reference><Citation>F. P. D. Reis, F. LM, L. G. Abdalla, et al., “Brazilian Initial Experience With Lung Transplantation Due to Irreversible Lung Fibrosis Post‐COVID‐19 in a National Reference Center: A Cohort Study,” Sao Paulo Medical Journal 140 (2021): 153–159, https://doi.org/10.1590/1516‐3180.2021.0842.R1.13102021.</Citation></Reference><Reference><Citation>D. Razia, R. M. Bremner, A. Omar, R. Walia, and S. Tokman, “Lung Transplantation for COVID‐19‐Induced Respiratory Failure: Single‐Center Case Series,” Journal of Heart and Lung Transplantation 41, no. 4 (2022): S480, https://doi.org/10.1016/j.healun.2022.01.1215.</Citation></Reference><Reference><Citation>M. I. Morrison, T. L. Pither, and A. J. Fisher, “Pathophysiology and Classification of Primary Graft Dysfunction After Lung Transplantation,” Journal of Thoracic Disease 9, no. 10 (2017): 4084–4097, https://doi.org/10.21037/jtd.2017.09.09.</Citation></Reference><Reference><Citation>T. Jefferson, E. A. Spencer, J. Brassey, and C. Heneghan, “Viral Cultures for COVID‐19 Infectious Potential Assessment—A Systematic Review,” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 77, (2020): 220–228, ciaa1764, https://doi.org/10.1093/cid/ciaa1764. Published online December 3.</Citation></Reference><Reference><Citation>R. Osborn, M. Alamri, R. Tomic, and M. G. Ison, “Infectious Complications of Lung Transplant for Coronavirus Disease 2019‐Associated Lung Injury: A Single‐Center Case‐Control Cohort Study,” Clinical Infectious Diseases 77, no. 2 (2023): 220–228, https://doi.org/10.1093/cid/ciad160.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>